Modern oncology is currently witnessing a paradigm shift where the brute force of systemic chemotherapy is being replaced by sophisticated molecular delivery systems designed to spare healthy tissue. While traditional treatments often ravage the entire body to reach a localized tumor, the
The persistent challenge of treating glioblastoma multiforme has long remained one of the most formidable frontiers in modern oncology due to the aggressive nature of these tumors and the restrictive blood-brain barrier. For decades, the standard of care has relied heavily on surgical resection
While modern medicine has traditionally viewed oncology through the narrow lens of localized tumor growth, a paradigm shift is occurring as researchers recognize cancer as a systemic "metabolic thief" that reengineers the body's entire chemical landscape to fuel its survival. This biological
A groundbreaking cross-sectional study at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán has unveiled critical genetic insights that could redefine the standard of care for Mexican men diagnosed with stage IV prostate cancer. Historically, the genomic landscape of prostate
Introduction Recent veterinary breakthroughs suggest that the silent deterioration of muscle mass in aging canines might finally have a detectable genetic signature that identifies early signs of physical decline. This syndrome, known as cachexia, often acts as a shadow to malignant tumors,
The landscape of modern oncology is undergoing a dramatic transformation as clinicians and researchers move away from the systemic toxicity of traditional chemotherapy toward highly localized, minimally invasive interventions. Photothermal therapy represents one of the most promising frontiers in
